Biological Therapy Analysis & Statistics in Australia, May 2013

You might be interested in: stem cell, cell therapy, cytokine, more »

» Purchase Premium Reports

1-12 of 12 reports
Cryosite Limited (Symbol:CTE) SWOT Analysis, Strategy, Revenues and Profits

Cryosite Limited (Symbol:CTE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Australia
Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2013
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a biomedical technology company, based in Australia. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. ...

  • Industries : Biological Therapy
  • Countries : Australia
Other Immunological Disorders - Pipeline Review, H2 2012

Other Immunological Disorders - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • August 2012
  • by Global Markets Direct

Other Immunological Disorders - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Other Immunological Disorders - Pipeline Review, H2 2012', provides an overview of the Other Immunological Disorders ...

  • Industries : Biological Therapy
  • Countries : World, Australia
Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2012
  • by Global Data

Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Tissue Therapies Limited (TTL) is a publicly held Australian based biotechnology company. The company ...

  • Industries : Biological Therapy
  • Countries : Australia
Delving into Stem Cell Research and its Potential

Delving into Stem Cell Research and its Potential

  • $ 350
  • Industry report
  • January 2012
  • by Aruvian's R'search

Stem cells are primal cells found in all multi-cellular organisms that retain the ability to renew themselves through mitotic cell division and can differentiate into a wide range of specialized cell types. ...

  • Industries : Biological Therapy
  • Countries : World, Australia, United States, United Kingdom, Europe, Canada, Germany, Japan, Israel, China
Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment

Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment

  • $ 3 500
  • Industry report
  • December 2011
  • by GBI Research

Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment Summary GBI Research's report, ?Oncology Devices Market ...

  • Industries : Biological Therapy
  • Countries : World, Australia, Brazil, Canada, Spain, Italy, Germany, Japan, India, China, France, United States, United Kingdom, Europe, Oceania, Asia, South America, North America
Mesoblast Ltd (Symbol:MSB) SWOT Analysis, Strategy, Revenues and Profits

Mesoblast Ltd (Symbol:MSB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Australia
Amgen: Pipeline - Products ? Performance - Potential

Amgen: Pipeline - Products ? Performance - Potential

  • $ 1 041
  • Company report
  • November 2010
  • by Espicom Business Intelligence

Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance ...

  • Industries : Biological Therapy
  • Countries : United States, Europe, Australia
Global Lou Gehrig's Disease industry

Global Lou Gehrig's Disease industry

  • $ 3 450
  • Industry report
  • April 2010
  • by Global Industry Analyst

This report analyzes the Global market for Lou Gehrig's Disease in US$ Million. Annual estimates and forecasts are provided for the period 2006 through 2015. The report profiles 37 companies including ...

  • Industries : Biological Therapy
  • Countries : World, United States, Canada, Australia, United Kingdom, France, Germany, Europe, North America, New Zealand, Oceania, Sweden, Taiwan, Israel
Top 20 Cancer Therapy Brands in Australia Forecast

Top 20 Cancer Therapy Brands in Australia Forecast

  • $ 5 700
  • Industry report
  • March 2010
  • by Datamonitor

Introduction The Top 20 cancer therapy brands in Australia reached sales of about $545m in 2008, growing at a CAGR of 30% since 2005. Datamonitor forecasts this growth to slow down considerably to a CAGR ...

  • Industries : Biological Therapy, Therapy
  • Countries : Australia
Cellestis Limited SWOT Analysis and Financial Profile

Cellestis Limited SWOT Analysis and Financial Profile

  • $ 125
  • Company report
  • August 2009
  • by Global Markets Direct

The industry player products are medical diagnosis, scientific research and line in tube blood incubation step. Cellestis develops and industry s QuantiFERON technology products for medical diagnosis ...

  • Industries : Biological Therapy, Medical Equipment and Supply
  • Countries : United States, World, Australia, Japan
Antisense Therapeutics Limited Financial Analysis

Antisense Therapeutics Limited Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

It is engaged in creating, development and commercializing of novel antisense pharmaceuticals. The firm ?s research and development activities are focused on developing antisense drugs. The firm ?s product ...

  • Industries : Biological Therapy, Pharmaceutical
  • Countries : Australia, Czech Republic, World


» Download Public Reports

44 reports
Company Report: Biological Therapy in Europe and Australia for Year 2012

Company Report: Biological Therapy in Europe and Australia for Year 2012

  • Company report
  • February 2012
  • 4 pages
  • by Market Research Publisher

... Relevant to rheumatoid arthritis, Dr french said. Dr french said that by specifically silencing various genes benitec S dna-directed rna interference (ddrnai) technology was capable of modulating stem cells ...


Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.